Prevalence of Vision Loss in High-Income Countries and in Eastern and Central Europe in 2020: Magnitude and Temporal Trends.

IF 1.7 4区医学 Q3 OPHTHALMOLOGY

Ophthalmic epidemiology Pub Date : 2025-05-15 DOI:10.1080/09286586.2025.2486461

{"title":"Prevalence of Vision Loss in High-Income Countries and in Eastern and Central Europe in 2020: Magnitude and Temporal Trends.","authors":"","doi":"10.1080/09286586.2025.2486461","DOIUrl":null,"url":null,"abstract":"Purpose: To estimate the prevalence of vision loss for 2020 in high-income countries (HICs) and Central/Eastern Europe and analyse evolving trends since 1990.Methods: Based on a systematic review of medical literature, prevalence of blindness, moderate and severe vision impairment (MSVI), mild vision impairment (VI), moderate VI and presbyopia were estimated for 1990, 2000, 2010, and 2020.Results: The study included 68 population-based studies. In the whole study region, the age-standardized prevalence (all ages) of blindness, MSVI, moderate VI, severe VI, mild VI, and presbyopia-related VI was 0.17% (95% CI:0.15-0.19), 2.27% (2.05-2.49), 2.06% (1.84-2.29), 0.21% (0.18-0.23), 1.79% (1.62-1.99), and 2.61% (1.88-3.48) respectively, with slightly higher rates for women than men. The prevalence rates were higher in Central/Eastern Europe than in the HIC, and lower than the global rates. Stratified between Australasia, high-income Asia Pacific region, high-income North America, Western Europe, Central Europe, and Eastern Europe, the age-standardized prevalence of blindness changed between 2000 and 2020 for men aged 50+ years by -7.95% (-8.11/-7.78), -14.51% (-14.64/-14.38), +13.18% (+13.00/+13.36), -12.07% (-12.23/-11.91), -14.39% (-14.54/-14.23), and -23.59% (-23.72/-23.46), respectively, without significant sex-related differences. Highest increase was in high-income North America (+13.18% (+13.00/+13.36)) and most marked reduction in Eastern Europe (-23.59% (-23.72/-23.46)). Estimated blind individuals were stratified as follows: Australasia, 68,866 (54,913-84,527), high-income Asia Pacific region, 535,124 (439,912-640,330), high-income North America, 711,990 (575,977-867,402), Western Europe, 1,533,752 (1,218,371-1,898,343), Central Europe, 327,352 (264,513-398,083) and Eastern Europe, 789,618 (663,130-923,121).Conclusions: Age-standardized prevalence of blindness and MSVI have further decreased in HIC and Eastern/Central Europe (except for high-income North America with an increase).","PeriodicalId":19607,"journal":{"name":"Ophthalmic epidemiology","volume":" ","pages":"1-14"},"PeriodicalIF":1.7000,"publicationDate":"2025-05-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ophthalmic epidemiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/09286586.2025.2486461","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Purpose: To estimate the prevalence of vision loss for 2020 in high-income countries (HICs) and Central/Eastern Europe and analyse evolving trends since 1990.

Methods: Based on a systematic review of medical literature, prevalence of blindness, moderate and severe vision impairment (MSVI), mild vision impairment (VI), moderate VI and presbyopia were estimated for 1990, 2000, 2010, and 2020.

Results: The study included 68 population-based studies. In the whole study region, the age-standardized prevalence (all ages) of blindness, MSVI, moderate VI, severe VI, mild VI, and presbyopia-related VI was 0.17% (95% CI:0.15-0.19), 2.27% (2.05-2.49), 2.06% (1.84-2.29), 0.21% (0.18-0.23), 1.79% (1.62-1.99), and 2.61% (1.88-3.48) respectively, with slightly higher rates for women than men. The prevalence rates were higher in Central/Eastern Europe than in the HIC, and lower than the global rates. Stratified between Australasia, high-income Asia Pacific region, high-income North America, Western Europe, Central Europe, and Eastern Europe, the age-standardized prevalence of blindness changed between 2000 and 2020 for men aged 50+ years by -7.95% (-8.11/-7.78), -14.51% (-14.64/-14.38), +13.18% (+13.00/+13.36), -12.07% (-12.23/-11.91), -14.39% (-14.54/-14.23), and -23.59% (-23.72/-23.46), respectively, without significant sex-related differences. Highest increase was in high-income North America (+13.18% (+13.00/+13.36)) and most marked reduction in Eastern Europe (-23.59% (-23.72/-23.46)). Estimated blind individuals were stratified as follows: Australasia, 68,866 (54,913-84,527), high-income Asia Pacific region, 535,124 (439,912-640,330), high-income North America, 711,990 (575,977-867,402), Western Europe, 1,533,752 (1,218,371-1,898,343), Central Europe, 327,352 (264,513-398,083) and Eastern Europe, 789,618 (663,130-923,121).

Conclusions: Age-standardized prevalence of blindness and MSVI have further decreased in HIC and Eastern/Central Europe (except for high-income North America with an increase).

查看原文本刊更多论文

2020年高收入国家及东欧和中欧视力丧失患病率：规模和时间趋势

目的：估计2020年高收入国家（HICs）和中欧/东欧视力丧失的患病率，并分析1990年以来的发展趋势。方法：在系统回顾医学文献的基础上，对1990年、2000年、2010年和2020年中国失明、中重度视力障碍（MSVI）、轻度视力障碍（VI）、中度视力障碍（VI）和老花眼的患病率进行统计。结果：该研究包括68项基于人群的研究。在整个研究区域，失明、重度VI、中度VI、重度VI、轻度VI和老花眼相关VI的年龄标准化患病率（所有年龄段）分别为0.17% （95% CI:0.15 ~ 0.19）、2.27%（2.05 ~ 2.49）、2.06%（1.84 ~ 2.29）、0.21%（0.18 ~ 0.23）、1.79%（1.62 ~ 1.99）和2.61%(1.88 ~ 3.48)，其中女性略高于男性。中欧/东欧的流行率高于高收入国家，低于全球流行率。在大洋洲、高收入亚太地区、高收入北美、西欧、中欧和东欧地区分层，2000 - 2020年50岁以上男性的年龄标准化失明患病率分别为-7.95%（-8.11/-7.78）、-14.51%（-14.64/-14.38）、+13.18%（+13.00/+13.36）、-12.07%（-12.23/-11.91）、-14.39%（-14.54/-14.23）和-23.59%(-23.72/-23.46)，性别差异不显著。增长最高的是高收入的北美（+13.18%(+13.00/+13.36)），下降最明显的是东欧（-23.59%(-23.72/-23.46)）。估计的盲人人数分层如下：澳大利亚，68,866(54,913-84,527)，高收入亚太地区，535,124(439,912-640,330)，高收入北美，711,990(575,977-867,402)，西欧，1,533,752(1,218,371-1,898,343)，中欧，327,352（264,513-398,083）和东欧，789,618（663,130-923,121）。结论：HIC和东欧/中欧的年龄标准化失明和MSVI患病率进一步下降（除了高收入的北美增加）。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Ophthalmic epidemiology 医学-眼科学

CiteScore

3.70

自引率

5.60%

发文量

审稿时长

6-12 weeks

期刊介绍： Ophthalmic Epidemiology is dedicated to the publication of original research into eye and vision health in the fields of epidemiology, public health and the prevention of blindness. Ophthalmic Epidemiology publishes editorials, original research reports, systematic reviews and meta-analysis articles, brief communications and letters to the editor on all subjects related to ophthalmic epidemiology. A broad range of topics is suitable, such as: evaluating the risk of ocular diseases, general and specific study designs, screening program implementation and evaluation, eye health care access, delivery and outcomes, therapeutic efficacy or effectiveness, disease prognosis and quality of life, cost-benefit analysis, biostatistical theory and risk factor analysis. We are looking to expand our engagement with reports of international interest, including those regarding problems affecting developing countries, although reports from all over the world potentially are suitable. Clinical case reports, small case series (not enough for a cohort analysis) articles and animal research reports are not appropriate for this journal.